Education And Data Will Be Key To Byooviz Uptake

Real-World Evidence Is Expected To Help Build Confidence In US Lucentis Biosimilar

 
• By David Wallace
  
Generate a summary of this article
Listen to this article
Beta

Education for healthcare professionals and real-world evidence will be important factors in building trust in Byooviz, Samsung Bioepis and Biogen have told Generics Bulletin, acknowledging it will “take some time” for ophthalmologists to grow more comfortable prescribing biosimilars.

Eye data binary
Generating more data for Byooviz will help build trust in the biosimilar • Source: Shutterstock

While Samsung Bioepis and Biogen made clear their intention to compete on price as they launched their Byooviz (ranibizumab-nuna) US biosimilar rival to Lucentis at the start of this month – at a 40% discount to the brand (Also see "Samsung Bioepis Goes After Lucentis With 40% Cheaper Byooviz Launch In US" - Generics Bulletin, 2 June, 2022.) – the pair have also underlined that education for healthcare professionals and generating additional real-world evidence on the biosimilar will be important factors in building trust and encouraging uptake.

Having spoken to Generics Bulletin about key aspects of the launch such as supply security (see sidebar), Samsung Bioepis executive...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.